Imperva Inc (IMPV) Given Consensus Recommendation of “Hold” by Brokerages

Imperva Inc (NASDAQ:IMPV) has been given an average rating of “Hold” by the twenty brokerages that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $53.23.

Several equities analysts have recently issued reports on the stock. BidaskClub raised shares of Imperva from a “hold” rating to a “buy” rating in a report on Tuesday. Zacks Investment Research downgraded shares of Imperva from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 11th. DA Davidson assumed coverage on shares of Imperva in a report on Tuesday, April 10th. They set a “buy” rating and a $56.00 price target for the company. ValuEngine downgraded shares of Imperva from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Finally, Imperial Capital boosted their price target on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, February 9th.

How to Become a New Pot Stock Millionaire

In other Imperva news, Director Anthony J. Bettencourt sold 66,037 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total value of $3,102,418.26. Following the sale, the director now directly owns 66,037 shares in the company, valued at $3,102,418.26. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CRO Michael D. Mooney sold 24,454 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the completion of the sale, the executive now owns 24,454 shares in the company, valued at $1,153,739.72. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Institutional investors have recently modified their holdings of the business. Wells Fargo & Company MN raised its position in Imperva by 11.9% in the third quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock worth $9,285,000 after acquiring an additional 22,741 shares in the last quarter. Renaissance Technologies LLC raised its position in Imperva by 55.2% in the fourth quarter. Renaissance Technologies LLC now owns 798,100 shares of the software maker’s stock worth $31,685,000 after acquiring an additional 283,700 shares in the last quarter. Triarii Capital Management LP bought a new stake in Imperva in the fourth quarter worth about $5,558,000. Bank of New York Mellon Corp raised its position in Imperva by 10.8% in the third quarter. Bank of New York Mellon Corp now owns 150,752 shares of the software maker’s stock worth $6,542,000 after acquiring an additional 14,727 shares in the last quarter. Finally, Global Financial Private Capital LLC raised its position in Imperva by 62.9% in the fourth quarter. Global Financial Private Capital LLC now owns 12,255 shares of the software maker’s stock worth $487,000 after acquiring an additional 4,730 shares in the last quarter.

Shares of IMPV traded up $0.35 during midday trading on Wednesday, hitting $47.65. 330,895 shares of the stock traded hands, compared to its average volume of 391,469. Imperva has a 1-year low of $37.17 and a 1-year high of $52.40. The company has a market cap of $1,646.33, a price-to-earnings ratio of -170.18, a price-to-earnings-growth ratio of 54.06 and a beta of 1.67.

Imperva (NASDAQ:IMPV) last announced its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.13. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The company had revenue of $91.10 million during the quarter, compared to the consensus estimate of $91.11 million. During the same quarter in the previous year, the company posted $0.32 earnings per share. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. equities analysts expect that Imperva will post 0.03 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Imperva Inc (IMPV) Given Consensus Recommendation of “Hold” by Brokerages” was reported by Week Herald and is the property of of Week Herald. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://weekherald.com/2018/04/18/imperva-inc-impv-given-consensus-recommendation-of-hold-by-brokerages.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply